Document:

EX-10.27

October 11, 2011

Rick S. Greene

1782 Penicuik Lane

Brentwood, TN 37027

	 	 	Re: Employment of Rick S. Greene as Vice President, Accounting & Finance and Chief Financial
Officer by Cumberland Pharmaceuticals Inc.

Dear Rick,

Effective October 18, 2011, this letter agreement (the “Agreement”) will evidence the terms and
conditions under which you will be employed by Cumberland Pharmaceuticals Inc. (the “Company”) In
consideration of your appointment as Vice President, Accounting & Finance and Chief Financial
Officer of the Company, and other good and valuable consideration, the receipt and sufficiency of
which is hereby acknowledged, the parties agree as follows:

1. Compensation. The Company agrees to compensate you as follows:

(a) The Company agrees to pay you on a salary basis for services performed based on an annual rate
of two hundred twenty thousand dollars ($220,000.00), payable in arrears in equal monthly
installments on the last day of each calendar month during the term of this Agreement.

(b) You will be eligible to participate in any Company-wide employee benefits as approved by the
Board of Directors. The terms of your eligibility and participation will be governed by the
provisions of the employee benefit plans, as such plans may be amended from time to time in the
discretion of the Company’s Board of Directors.

(c) You may be eligible for any Company bonus program, with a potential annual bonus of up to
$55,000, based upon performance in meeting your individual objectives and the Company’s overall
performance, both as determined and approved by the Board of Directors of the Company. Any such
bonus will be discretionary and will be subject to the terms of the applicable bonus program, the
terms of which program may be modified from year to year in the sole discretion of the Company’s
Board of Directors.

(d) You will receive a grant of 30,000 shares of Cumberland Pharmaceuticals common stock, pursuant
to a restricted stock agreement (RSA). These shares will vest at the four-year anniversary date of
the grant. Such shares, as defined in your signed Employment Term Sheet, will be subject to the RSA
and the terms set forth in the incentive compensation plan under which they are awarded.

(e) Except as set forth in Section 2, the Company shall not be liable to you for any expense
incurred by you unless you receive the Company’s prior written consent to reimburse you for such
expense.

2. Additional Payments.

(a) During the term hereof, you shall be entitled to receive prompt reimbursement for all
reasonable and documented expenses incurred in the performance of Services in accordance with the
expense reimbursement policy of the Company.

(b) Assuming you maintain an active license, the Company agrees to pay the following expenses
which are professional costs associated with your CPA: Tennessee Department of Revenue Professional
Privilege Tax, Continuing Professional Education (the Company will reimburse 32 hours of the 40
hours required per year), Tennessee Society of CPAs Annual Membership (excludes elective fees), and
the Tennessee State Board of Accounting License Fee.

3. Employment at Will. This Agreement is not intended to and shall not be understood in
any manner as affecting or modifying the at-will status of your employment with the Company. As an
at-will employee either you or the Company may terminate the employment relationship at any time
with or without cause or notice. The obligations of Sections 4, 5, 6, 7, 8, 10, 11 and 12 herein
shall survive the termination of the employment relationship or of this Agreement.

4. Confidentiality. All knowledge and information, not already available to the
public, which you acquire, have acquired, or will acquire in the course of your employment with the
Company with respect to the Company’s business, work methods, or pending regulatory matters, or
other Company matters that are treated by the Company as confidential, shall be regarded by you as
trade secrets, whether or not they are classifiable legally as trade secrets, and shall be treated
by you as strictly confidential. Such knowledge and information shall not either directly or
indirectly be used, disclosed, or made accessible to anyone by you for any purpose, except in the
ordinary course of the Company’s business under circumstances in which you are authorized to use or
disclose such information. No disclosures of such confidential information shall be made outside
of those you are authorized to make in the regular and ordinary course of your duties unless and
until you receive prior written permission of the Board of Directors of the Company to make such
disclosure.

5. Discoveries and Improvements. During the time that you are employed by the
Company, all confidential information, trade secrets, or proprietary information and all other
discoveries, inventions, software programs, processes, methods and improvements that are conceived,
developed, or otherwise made by you , alone or with others, that relate in any way to the Company’s
present or planned business or products (collectively the “Developments”), whether or not
patentable or subject to copyright protection and whether or not reduced to tangible form or
reduced to practice, shall be the sole property of the Company. You agree to disclose all
Developments promptly, fully and in writing to the Company. You agree to keep and maintain
adequate and current dated and witnessed written records of all such Developments, in the form of
notes, sketches, drawings, or reports, which records shall be promptly submitted to the Company
and shall be and remain the property of the Company at all times. You agree to assign, and hereby
do assign, to, the Company all your right, title and interest throughout the world in and to all
Developments. You agree that all Developments shall constitute “Works for Hire” (as such are
defined under the U.S. Copyright Laws) and hereby assign to the Company all copyrights, patents and
other proprietary rights you may have in any Developments without any obligation on the part of the
Company to pay royalties or any other consideration to you for such Developments.

6. Publication. All documents and other writings produced by you during the period of your
employment, which relate to work you are doing or have done for the Company or to the business of
the Company or its affiliates, shall belong to the Company. You will not publish outside of the
Company any such writing without the prior written consent of the Board of Directors of the
Company. You will, without further compensation, execute at any time (whether or not you are still
employed by the Company) all documents requested of you relating to the protection of such rights,
including the assignment of such rights to the Company.

7. Litigation. You shall notify the Company within three business days if no longer
employed and immediately if still employed by the Company if you are contacted by any person
relating to any claim or litigation against the Company. You shall not communicate in any manner
with any person related to any claim or litigation against the Company without the prior consent of
the Board of Directors of the Company unless compelled to do so by law.

8. Competition. For so long as you are employed by the Company or any Affiliate (as
defined below) and for a period of one year after you cease to be employed by the Company or any
Affiliate, you shall not, directly or indirectly, engage in any work or other activity—whether as
owner, stockholder, partner, officer, consultant, or otherwise—involving a trademark, product, or
process that, in the opinion of the Company’s President, is similar to a trademark, product or
process on which you worked for the Company (or any Affiliate) or obtained knowledge about while
working for the Company at any time during the period of employment, if such work or other activity
is then, or reasonably expected to become, competitive with that of the Company (or any Affiliate).
The restriction in the preceding sentence shall not apply if you have disclosed to the Company in
writing all the known facts relating to such work or activity and have received a release in
writing from the Board of Directors of the Company allowing you to engage in such work or activity.
The Company’s President shall have sole discretion to determine whether your work or activity for
another employer involves trademarks, products, or processes that are similar to trademarks,
products, or processes that you worked on for the Company. Ownership by you of five percent (5%) or
less of the outstanding shares of stock of any company either (i) listed on a national securities
exchange, or (ii) having at least one hundred (100) stockholders shall not make you a “stockholder”
within the meaning of that term as used in this paragraph. For one year after you cease to work
for the Company, you will not engage in any work or activity that will cause you to inevitably
disclose to anyone not employed by the Company (or an Affiliate) any trade secret or confidential
information that belongs to the Company or one of its Affiliates. Nothing in this paragraph shall
limit the rights or remedies of the Company arising, directly or indirectly, from such competitive
employment, including, without limitation, claims based upon breach of fiduciary duty,
misappropriation, or theft of confidential information. The term “Affiliate” shall mean the
Company and any entity controlling, controlled by, or under common control with the Company.

9. Conflicting Contracts. You represent and warrant that you are not now under any
obligation resulting from any contract or arrangement, to any person, firm, or corporation, which
is inconsistent or in conflict with this Agreement. Likewise you represent and warrant that you
are not now under any obligation resulting from any contract or arrangement to any person, firm, or
corporation which would prevent, limit, or impair in any way the performance by you of your
obligations to the Company.

10. Solicitation. For a period of one year after you cease to be employed by the Company
(or a Company affiliate):

(a) You agree not to solicit, directly or indirectly, business related to the development or sales
of pharmaceutical products from any entity, organization, or person which is contracted with the
Company, which has been doing business with the Company or from which the Company was soliciting at
the time of your termination, or a firm which you knew or had reason to know that the Company was
going to solicit business at the time you ceased to be employed by the Company. The restriction
set forth in the preceding sentence shall not apply if you have disclosed to the Company in writing
all the known facts relating to such solicitation and have received a release in writing from the
Board of Directors of the Company to engage in such solicitation.

(b) You agree not to solicit, recruit, hire, or assist in the hiring of any employee of the Company
to work for you or another person, firm, corporation, or business in competition with, or
reasonably likely to become in competition with, the Company.

11. Return of Documents. Upon termination of your employment for any reason, you shall
immediately return to the Company all documents and things belonging to the Company. This
includes, but is not limited to, trade secrets, confidential information, knowledge, data or
know-how, and software containing such information, whether or not the documents are marked
“Confidential.”

12. Remedies. You acknowledge that in the event of breach of this Agreement by you, actual
damages to the Company will be impossible to calculate, the Company’s remedies at law will be
inadequate, and the Company will suffer irreparable harm. Therefore, you agree that any of the
covenants contained in this Agreement may be specifically enforced through injunctive relief, but
such right to injunctive relief shall not preclude the Company from other remedies which may be
available to it. You further agree that should you fail to keep any of the promises made by you in
this Agreement, or any way violate this Agreement, the Company shall be entitled to recover all
monies the Company is required to spend, including attorneys fees, to enforce the provisions of
this Agreement.

13. Best Efforts and Conflicts of Interest: You are hired with the understanding that
Cumberland is your sole employer and you will provide a full-time work effort. You agree to devote
your entire professional and business-related time and best efforts to the services required of you
by the express and implicit terms of this Agreement, to the reasonable satisfaction of Cumberland
in its sole and complete discretion. Engaging in activities outside of work that create a conflict
of interest, or detract from your ability to perform your assigned responsibilities or meet your
defined goals and objectives with Cumberland, is a problem and may lead to disciplinary action up
to and including termination of employment. If you believe that you are potentially involved in a
situation that could create a conflict of interest and affect your ability to adequately perform
your job with Cumberland, you should immediately inform your direct supervisor and Cumberland’s
Human Resources Department and receive approval to continue these activities.

14. Debarment. You represent and warrant that you have not been debarred and will
notify the Company immediately if you are debarred, pursuant to subsection 306(a) or 306(b) of the
Federal Food, Drug, and Cosmetic Act.

15. Notice. Any notice required or permitted to be given under this Agreement shall
be sufficient if in writing and if sent by registered or certified mail to your residence or to the
Company’s principal office in the case of the Company.

16. Waiver. The waiver by either party of any provision of this Agreement shall not
operate or be construed as a waiver of any subsequent breach.

17. Entire Agreement. This Agreement contains the entire agreement of the parties and
may not be changed orally, but only by an agreement in writing signed by the party against whom
enforcement of any waiver, change, modification, extension, or discharge is sought.

18. Governance. This Agreement shall be governed by the laws of the State of
Tennessee. Any dispute arising out of this Agreement shall be resolved, at the Company’s sole
option, by courts sitting in Nashville, Tennessee, and you waive any objection to such venue.

19. Enforceability. In the event that any provision of this Agreement shall be held
by a court to be unenforceable, such provision will be enforced to the maximum extent permissible,
and the remaining portions of this Agreement shall remain in full force and effect.

20. Survival. Notwithstanding any termination of your employment, this Agreement shall
survive and remain in effect in accordance with its terms.

This letter agreement may be signed in one or more counterparts, each of which shall be an
original and all of which will constitute one and the same instrument.

Sincerely yours,

CUMBERLAND PHARMACEUTICALS INC.

	 	 	 	 	 
	 	 	___/s/ A. J. Kazimi
	 	 	 
	
 
	 	By:
	 	A.J. Kazimi

Chief Executive Officer
	Accepted as to all terms and conditions

as of the 11th of October, 2011:

	 	

	 	

	/s/ Rick S. Greene

	 	

	 	

	 

	 	

	 	

Rick S. GreeneEX-10.1

EXHIBIT 10.1

AMENDMENT

NO. 3

TO

THIRD AMENDED AND RESTATED PRECIOUS METALS AGREEMENT

THIS AMENDMENT NO. 3 TO THIRD AMENDED AND RESTATED PRECIOUS METALS AGREEMENT (this
“Amendment”) is made as of October 17, 2011, by and among THE BANK OF NOVA SCOTIA, a
Canadian chartered bank (the “Metal Lender”); MATERION CORPORATION (f/k/a Brush Engineered
Materials Inc.), an Ohio corporation (“BEM”); MATERION ADVANCED MATERIALS TECHNOLOGIES AND
SERVICES INC. (f/k/a Williams Advanced Materials Inc.), a New York corporation (“WAM”);
MATERION TECHNICAL MATERIALS INC. (f/k/a Technical Materials, Inc.), an Ohio corporation
(“TMI”); MATERION BRUSH INC. (f/k/a Brush Wellman Inc.), an Ohio corporation
(“BWI”); MATERION TECHNOLOGIES INC. (f/k/a Zentrix Technologies Inc.), an Arizona
corporation (“ZTI”); MATERION BREWSTER LLC (f/k/a Williams Acquisition, LLC), a New York
limited liability company d/b/a Pure Tech (“Pure Tech”); MATERION PRECISION OPTICS AND THIN
FILM COATINGS CORPORATION (f/k/a Thin Film Technology, Inc.), a California corporation
(“TFT”); MATERION LARGE AREA COATINGS LLC (f/k/a Techni-Met, LLC), a Delaware limited
liability company (“TML”); MATERION ADVANCED MATERIALS TECHNOLOGIES AND SERVICES CORP.
(f/k/a Academy Corporation), a New Mexico corporation (“AC”); MATERION ADVANCED MATERIALS
TECHNOLOGIES AND SERVICES LLC (f/k/a Academy Gallup, LLC), a New Mexico limited liability company
(“AG”); and such other Subsidiaries of BEM who may from time to time become parties by
means of their execution and delivery with the Metal Lender of a Joinder Agreement under the
Precious Metals Agreement (as defined below). BEM, WAM, TMI, BWI, ZTI, Pure Tech, TFT, TML, AC, AG
and such Subsidiaries are herein sometimes referred to collectively as the “Customers” and
each individually as a “Customer”.

WITNESSETH:

WHEREAS, the Metal Lender and the Customers are parties to a certain Third Amended and
Restated Precious Metals Agreement, effective as of October 1, 2010, as amended by that certain
Amendment No. 1, dated as of March 31, 2011, that certain Amendment No. 2, dated as of August 18,
2011 (as amended, the “Precious Metals Agreement”); and

WHEREAS, the parties hereto desire to amend certain provisions of the Precious Metals
Agreement as hereinafter provided;

NOW, THEREFORE, for value received and for other good and valuable consideration, the receipt
and adequacy of which are hereby acknowledged, the parties hereto hereby amend the Precious Metals
Agreement and agree, effective as of the date first written above, as follows:.

1. Amendments.

(a) The definition of “Consignment Limit” appearing in Section 1 of the Precious Metals
Agreement is hereby amended and restated in its entirety to read as follows:

“Consignment Limit” means (a) the lesser of: (i) Two Hundred
Million Dollars ($200,000,000); and (ii) the value (as determined in
accordance with Section 2.2 hereof) of the Customers’
Inventory of Precious Metal (including any Precious Metal obtained
or, at the time of determination, proposed to be obtained, by a
Customer pursuant to this Agreement) at Approved Locations or in
transit between any Approved Locations which is (A) not outstanding
on consignment, loan or lease to the Customers from Approved
Consignors under Permitted Precious Metals Agreements, and (B) is
free and clear of all Liens other than Permitted Metal Liens, minus
(b) the Gold Loan Facility Indebtedness.

(b) The definition of “Gold Loan Limit” appearing in Section 1 of the Precious Metals
Agreement is hereby amended and restated in its entirety to read as follows:

“Gold Loan Limit” means the lesser of (a) the value (as
determined in accordance with Section 2.2 hereof) of 23,781
fine troy ounces of Gold, and (b) Two Hundred Million Dollars
($200,000,000), minus the Consignment Facility Indebtedness.

(c) Schedule 1 (Approved Locations) to the Precious Metals Agreement is hereby amended
by adding the following company and location as an Approved Subconsignee and Approved
Subconsignment Location, respectively, under the applicable heading:

Cree, Inc.

4600 Silicon Drive

Durham, North Carolina 27703

(d) Schedule 1 (Approved Locations) to the Precious Metals Agreement is hereby amended
by adding the following location as an Approved Foreign Location under the applicable heading:

Materion Advanced Materials Technologies and Services Far East Pte. Ltd.

28 Woodlands Loop #01-00

Singapore 738308

2. Representations and Warranties. To induce the Metal Lender to enter into this
Amendment, each Customer hereby represents and warrants to the Metal Lender that: (a) such
Customer has full power and authority, and has taken all action necessary, to execute and deliver
this Amendment and to fulfill its obligations hereunder and to consummate the transactions
contemplated hereby; (b) the making and performance by such Customer of this Amendment do not and
will not violate any law or regulation of the jurisdiction of its organization or any other law or
regulation applicable to it; (c) this Amendment has been duly executed and delivered by such
Customer and constitutes the legal, valid and binding obligation of such Customer, enforceable
against it in accordance with its terms, except as enforceability may be limited by bankruptcy,
insolvency or similar laws affecting the enforcement of creditors’ rights generally and except as
the same may be subject to general principles of equity; and (d) on and as of the date hereof,
after giving effect to this Amendment, no Default or Event of Default exists under the Precious
Metals Agreement.

3. Governing Law. This Amendment shall be governed by and construed in accordance
with the laws of the State of New York applicable to contracts made and performed in such State.

4. Integration. The Precious Metals Agreement, as amended hereby, together with the
other Precious Metal Documents, is intended by the parties as the final, complete and exclusive
statement of the transactions evidenced by the Precious Metals Agreement. All prior or
contemporaneous promises, agreements and understandings, whether oral or written, are deemed to be
superseded by the Precious Metals Agreement, as amended hereby, and no party is relying on any
promise, agreement or understanding not set forth in the Precious Metals Agreement, as amended
hereby. The Precious Metals Agreement, as amended hereby, may not be amended or modified except by
a written instrument describing such amendment or modification executed by the Customers and the
Metal Lender. The parties hereto agree that this Amendment shall in no manner affect or impair the
liens and security interests evidenced or granted by the Precious Metals Agreement or in connection
therewith.

5. Ratification. Except as amended hereby, the Precious Metals Agreement shall remain
in full force and effect and is in all respects hereby ratified and affirmed.

6. Signatures. This Amendment may be executed by the parties hereto in several
counterparts hereof and by the different parties hereto on separate counterparts hereof, each of
which shall be an original and all of which shall together constitute one and the same agreement.
Delivery of an executed signature page of this Amendment by electronic transmission shall be
effective as an in hand delivery of an original executed counterpart hereof.

[Signature Page Follows] IN WITNESS WHEREOF, the undersigned parties have caused this
Amendment to be executed by their duly authorized officers as of the date first written above.

	 	 	 
	CUSTOMERS:	 	 
	MATERION CORPORATION

By: /s/ Michael C. Hasychak

Michael C. Hasychak

Vice President, Treasurer and Secretary

	 	MATERION ADVANCED MATERIALS TECHNOLOGIES

AND SERVICES INC.

By: /s/ Michael C. Hasychak

—

Michael C. Hasychak

Vice President, Treasurer and Secretary
	MATERION TECHNICAL MATERIALS INC.

By: /s/ Michael C. Hasychak

	 	MATERION BRUSH INC.

By: /s/ Michael C. Hasychak
	 

	 	 
	Michael C. Hasychak

Vice President, Treasurer and Secretary

	 	Michael C. Hasychak

Vice President, Treasurer and Secretary
	MATERION TECHNOLOGIES INC.

By: /s/ Michael C. Hasychak

	 	MATERION BREWSTER LLC

By: /s/ Michael C. Hasychak
	 

	 	 
	Michael C. Hasychak

Chief Financial Officer and Secretary

	 	Michael C. Hasychak

Treasurer
	MATERION PRECISION OPTICS AND THIN FILM

COATINGS CORPORATION

By: /s/ Gary W. Schiavoni

Gary W. Schiavoni

Secretary

	 	MATERION LARGE AREA COATINGS LLC

By: /s/ Gary W. Schiavoni

—

Gary W. Schiavoni

Asst. Secretary and Asst. Treasurer

	MATERION ADVANCED MATERIALS TECHNOLOGIES

AND SERVICES CORP.

By: /s/ Richard W. Sager

	 	MATERION ADVANCED MATERIALS TECHNOLOGIES

AND SERVICES LLC

	 

	 	

	Richard W. Sager

	 	By: /s/ Richard W. Sager
	
 
	 	 
	President

	 	Richard W. Sager

Manager
	METAL LENDER:

	 	

	 

	 	

	THE BANK OF NOVA SCOTIA

By: /s/ Bimal Das

	 	

By: /s/ Sangeeta Shah
	 

	 	 
	Name: Bimal Das

	 	Name: Sangeeta Shah
	 

	 	 
	Title: Director

	 	Title: Associate Director

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00195-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00195-of-00352.parquet"}]]